secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXAGEN INC. (XGN)
CIK:        0001274737
Form:       8-K
Filed at:   2023-07-24T23:59:59+00:00
Accession:  0001274737-23-000074
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exagen appoints Paul Kim to board of directors; Kim is CFO of Fulgent Genetics
------------------------------------------------------------------------------

- Paul Kim appointed to Exagen board as Class II director effective July 24, 2023.
- Kim also appointed to Audit Committee and Compensation Committee.
- Kim has served as CFO of Fulgent Genetics (FLGT) since 2016; previously CFO of Cogent, Inc.
- Kim received option to purchase 15,000 shares vesting over 3 years; standard director compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1274737/000127473723000074/0001274737-23-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1274737/000127473723000074/exdx-20230724.htm
  HTML page:      https://secwatch.observer/filing/0001274737-23-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer